Heather Lin

9.9k total citations
173 papers, 4.9k citations indexed

About

Heather Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Heather Lin has authored 173 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 53 papers in Pulmonary and Respiratory Medicine and 52 papers in Cancer Research. Recurrent topics in Heather Lin's work include Breast Cancer Treatment Studies (27 papers), Lung Cancer Treatments and Mutations (25 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Heather Lin is often cited by papers focused on Breast Cancer Treatment Studies (27 papers), Lung Cancer Treatments and Mutations (25 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Heather Lin collaborates with scholars based in United States, Brazil and Egypt. Heather Lin's co-authors include J. Jack Lee, Ignacio I. Wistuba, Isabelle Bedrosian, William N. William, Yu Shen, Carmen Behrens, Simona F. Shaitelman, Gildy V. Babiera, María E. Suarez‐Almazor and Edward S. Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Heather Lin

167 papers receiving 4.9k citations

Peers

Countries citing papers authored by Heather Lin

Since Specialization

Citations

This map shows the geographic impact of Heather Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Lin more than expected).

Fields of papers citing papers by Heather Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Lin. The network helps show where Heather Lin may publish in the future.

Co-authorship network of co-authors of Heather Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Lin. A scholar is included among the top collaborators of Heather Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Lin. Heather Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma 2025 ·Blood ·Qin Li, (unknown), Upasana Ray, Iqbal Mahmud, Lin Tan, Philip L. Lorenzi, Suyu Liu, Heather Lin, (unknown), (unknown), John D. Shaughnessy, Qing Yi, (unknown), Hua Wang, (unknown), Hans C. Lee, Krina K. Patel, Isere Kuiatse, David E. Symer, Robert Z. Orlowski	2
2	1209MO Neoadjuvant nivolumab and nivolumab+ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159 2024 ·Annals of Oncology ·Joshua E. Reuss, Cheuk Hong Leung, (unknown), Nicolas Zhou, (unknown), Apar Pataer, William N. William, Joseph H. Taube, Stephen Broderick, (unknown), David R. Jones, Don L. Gibbons, John V. Heymach, Valsamo Anagnostou, Heather Lin, J.J. Lee, Boris Sepesi, Jamie E. Chaft, (unknown), Tina Cascone	0
3	Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer 2023 ·SHILAP Revista de lepidopterología ·Ji Son, Heather Lin, Siqing Fu, Amadeo B. Biter, Ecaterina E. Dumbrava, Daniel D. Karp, Aung Naing, Shubham Pant, Sarina A. Piha‐Paul, Jordi Rodón, Vivek Subbiah, Apostolia M. Tsimberidou, Timothy A. Yap, Michael Frumovitz, Amir A. Jazaeri, Pedro T. Ramírez, Shannon N. Westin, Ying Yuan, Funda Meric‐Bernstam, David S. Hong	1
4	243MO Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial 2023 ·Annals of Oncology ·Henry M. Kuerer, Gaiane M. Rauch, Savitri Krishnamurthy, Emilia J. Diego, Wei Yang, Yu Shen, Heather Lin, Anthony Lucci, Timothy A. Moseley, (unknown), Jason Mouabbi, Judy C. Boughey, Simona F. Shaitelman, Richard L. White, Kelly K. Hunt, Melissa P. Mitchell, Mediget Teshome, Helen M. Johnson, Benjamin D. Smith, Vicente Valero	1
5	Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis 2022 ·SHILAP Revista de lepidopterología ·(unknown), Selvi Thirumurthi, Melissa W. Taggart, Bülent Yılmaz, Heather Lin, (unknown), (unknown), (unknown), Abdulrazzak Zarifa, Cheuk Hong Leung, David S. Hong, Raghu Vikram	5
6	Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma 2021 ·Cell Reports ·Richa Rathore, Katharine E. Caldwell, Charles R. Schutt, (unknown), Bethany C. Prudner, (unknown), Cheuk Hong Leung, Heather Lin, Najat C. Daw, Hannah C. Beird, (unknown), Wei‐Lien Wang, Alexander J. Lazar, John S.A. Chrisinger, J. Andrew Livingston, Brian Andrew Van Tine	38
7	Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis 2021 ·npj Breast Cancer ·David Boyce-Fappiano, Isabelle Bedrosian, Yu Shen, Heather Lin, Olsi Gjyshi, (unknown), Simona F. Shaitelman, Wendy A. Woodward	12
8	Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes 2019 ·Breast Cancer Research and Treatment ·Anna Weiss, Heather Lin, Gildy V. Babiera, Isabelle Bedrosian, Simona F. Shaitelman, Yu Shen, Henry M. Kuerer, Elizabeth A. Mittendorf, Abigail S. Caudle, Kelly K. Hunt, Rosa F. Hwang	21
9	Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients 2018 ·Molecular Cancer Therapeutics ·J. Andrew Livingston, Wei‐Lien Wang, Jen-Wei Tsai, Alexander J. Lazar, Cheuk Hong Leung, Heather Lin, Shailesh Advani, Najat C. Daw, (unknown), (unknown), Nancy Gordon, Eugenie S. Kleinerman	15
10	TUSC2 Immunogene Therapy Synergizes with Anti–PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras -Mutant Mouse Lung Cancer Models 2018 ·Cancer Immunology Research ·Ismail M. Meraz, Mourad Majidi, Xiaobo Cao, Heather Lin, Lerong Li, Jing Wang, Veera Baladandayuthapani, David C. Rice, Boris Sepesi, Lin Ji, Jack A. Roth	42
11	Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191 2018 ·Clinical Cancer Research ·(unknown), Fazal Shirazi, Veerabhadran Baladandayuthapani, Heather Lin, Isere Kuiatse, Hua Wang, Richard J. Jones, Zuzana Berkova, Yasumichi Hitoshi, Stephen M. Ansell, Steven P. Treon, Sheeba K. Thomas, Hans C. Lee, Zhiqiang Wang, R. Eric Davis, Robert Z. Orlowski	14
12	Factors associated with improved outcomes for metastatic inflammatory breast cancer patients 2018 ·Breast Cancer Research and Treatment ·Anna Weiss, (unknown), Heather Lin, Yu Shen, (unknown), Simona F. Shaitelman, Wendy A. Woodward, Vicente Valero, Naoto T. Ueno, Isabelle Bedrosian, Gildy V. Babiera	14
13	Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma 2017 ·Journal of Thoracic Oncology ·Anne S. Tsao, Heather Lin, Brett W. Carter, J. Jack Lee, David C. Rice, (unknown), S.G. Swisher, Reza J. Mehran, John V. Heymach, Monique B. Nilsson, You-Hong Fan, Maria I. Nuñez, Lixia Diao, Jing Wang, Junya Fujimoto, Ignacio I. Wistuba, Waun Ki Hong	9
14	Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations 2015 ·Cancer Research ·Erick Riquelme, Carmen Behrens, Heather Lin, George R. Simon, Vassiliki A. Papadimitrakopoulou, Julie Izzo, César A. Moran, Neda Kalhor, J. Jack Lee, John D. Minna, Ignacio I. Wistuba	85
15	Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia 2015 ·Clinical Cancer Research ·Isere Kuiatse, Veerabhadran Baladandayuthapani, Heather Lin, Sheeba K. Thomas, Chad C. Bjorklund, Donna M. Weber, Michael Wang, Jatin J. Shah, Xing‐Ding Zhang, Richard J. Jones, Stephen M. Ansell, Guang Yang, Steven P. Treon, Robert Z. Orlowski	16
16	VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy 2014 ·Clinical Cancer Research ·Erick Riquelme, Milind Suraokar, Carmen Behrens, Heather Lin, Luc Girard, Monique B. Nilsson, George R. Simon, Jing Wang, Kevin R. Coombes, J. Jack Lee, Waun Ki Hong, John V. Heymach, John D. Minna, Ignacio I. Wistuba	59
17	EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma 2013 ·Clinical Cancer Research ·Carmen Behrens, Luisa M. Solis, Heather Lin, Ping Yuan, Ximing Tang, Humam Kadara, Erick Riquelme, Héctor Galindo, César A. Moran, Neda Kalhor, Stephen G. Swisher, George R. Simon, David J. Stewart, J. Jack Lee, Ignacio I. Wistuba	123
18	Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy 2011 ·Cancer Research ·Fei Yang, Ximing Tang, Erick Riquelme, Carmen Behrens, Monique B. Nilsson, Uma Giri, Marileila Varella‐Garcia, Lauren A. Byers, Heather Lin, Jing Wang, Maria Gabriela Raso, Luc Girard, Kevin R. Coombes, J. Jack Lee, Roy S. Herbst, John D. Minna, John V. Heymach, Ignacio I. Wistuba	51
19	Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome 2011 ·Cancer ·Luisa M. Solis, Carmen Behrens, Maria Gabriela Raso, Heather Lin, Humam Kadara, Ping Yuan, Héctor Galindo, Ximing Tang, J. Jack Lee, Neda Kalhor, Ignacio I. Wistuba, César A. Moran	85
20	Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial 2009 ·Journal of Clinical Oncology ·Merrill S. Kies, Floyd Christopher Holsinger, J. Jack Lee, William N. William, Bonnie S. Glisson, Heather Lin, Jan S. Lewin, Lawrence E. Ginsberg, (unknown), Erminia Massarelli, Lauren A. Byers, Scott M. Lippman, Waun Ki Hong, Adel K. El‐Naggar, Adam S. Garden, Vassiliki A. Papadimitrakopoulou	187

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact